湯平，男，1973年出生，民盟盟員，醫(yī)學博士，美國Duke大學前列腺疾病中心博士后（2008-2009年)，廣州市第一人民醫(yī)院泌尿外科主任醫(yī)師，碩士生導師,廣東省泌尿外科中青年委員會、廣東省中西醫(yī)結合泌尿外科專業(yè)委員會、廣東省抗癌專業(yè)委員會泌尿外科分會委員，廣州市衛(wèi)生局、廣州市第一人民醫(yī)院優(yōu)秀科技人才，廣東省科技計劃項目、廣東省自然科學基金評審專家。從事泌尿外科專業(yè)10余年，臨床上以泌尿外科腹腔鏡、經(jīng)尿道前列腺電切術（TURP)、經(jīng)皮腎鏡術（PCN)等為主的微創(chuàng)手術為特色。2008年作為廣州市衛(wèi)生局重點�？启呙谀蛲饪剖着瞬排囵B(yǎng)人選f1411.cn，被派送到美國著名的Duke大學前列腺疾病中心學習，在前列腺癌的研究方面取得了重要的成績。主持包括國家自然基金、廣東省自然基金、廣州市衛(wèi)生局重點項目在內(nèi)的前列腺癌方向科研課題共6項，總經(jīng)費超過100萬元，以第一作者在世界泌尿外科主流雜志上發(fā)表SCI論著9篇，總影響因子近30分，獲得廣東省科技進步三等獎、廣州市科技進步三等獎各1項（均為第二完成人)。
代表性論文（附發(fā)表當年或最新影響因子)
1. Tang P, Du W, Xie K, et al. Transition zone PSA density improves the prostate cancer detection rate both in PSA4.0-10.0 and 10.1-20.0ng/ml in Chinese men. Urol Oncol. 2011 Aug 23. [Epub ahead of print] (IF 3.172)
2. Tang P, Du W, Xie K, et al. Characteristics of baseline PSA and PSA velocity in young men without prostate cancer: Racial differences. Prostate. 2012;72(2):173-80. (IF 3.377)
3. Tang P, Sun L, Uhlman MA, et al. Prostate-Specific Antigen Velocity Based Risk-Adapted Discontinuation of Prostate Cancer Screening in Elderly Men. BJU Int. 2011; 108 (1): 44-48. (IF 3.190)
4. Tang P, Sun L, Uhlman MA, et al. Baseline PSA as a predictor of prostate cancer-specific mortality over the past 2 decades: duke university experience. Cancer. 2010; 116(20):4711-4717. (IF 5.131)
5. Tang P, Xie KJ, Wang B, et al. Antibacterial therapy improves the effectiveness of prostate cancer detection using prostate-specific antigen in patients with asymptomatic prostatitis. Int Urol Nephrol. 2010; 42(1):13-18. (IF 1.567)
6. Tang P, Sun L, Uhlman MA,et al. Initial prostate specific antigen 1.5 ng/ml or greater in men 50 years old or younger predicts higher prostate cancer risk. J Urol. 2010; 183(3):946-950. (IF 3.862)
7. Tang P, Sun L, Uhlman MA, et al. Prostate-specific Antigen-based Risk-adapted Discontinuation of Prostate Cancer Screening in Elderly African American and Caucasian American Men. Urology. 2010; 76(5):1058-1062. (IF 2.334)
8. Moul JW , Tang P, Sun L. Editorial Comment on: Development of a New Method for Monitoring Prostate-Specific Antigen Changes in Men with Localised Prostate Cancer: A Comparison of Observational Cohorts. Eur Urol. 2010; 57(3):452. (IF 8.843)
